about
IL-17 and IL-22 in cerebrospinal fluid and plasma are elevated in Guillain-Barré syndromeIVIG treatment and prognosis in Guillain-Barré syndromeIntravenous immunoglobulin for Guillain-Barré syndromeCorticosteroids for Guillain-Barré syndromeTreatment for Fisher syndrome, Bickerstaff's brainstem encephalitis and related disordersCorticosteroids for Guillain-Barré syndromeCost-minimization analysis of the direct costs of TPE and IVIg in the treatment of Guillain-Barré syndrome.Clinical and pharmacological aspects of inflammatory demyelinating diseases in childhood: an update.Guidelines on the use of therapeutic apheresis in clinical practice--evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis.Pathogenesis and treatment of immune-mediated neuropathies.Treatment guidelines for Guillain-Barré Syndrome.Immune mediated diseases and immune modulation in the neurocritical care unitClinical characteristics of childhood guillain-barré syndrome.An update in guillain-barré syndromeAtypical findings of guillain-barré syndrome in childrenClinical applications of intravenous immunoglobulins in neurology.Guillain-Barré syndrome: a review.Atypical guillain-barré in the emergency department.Practical approach to the patient with acute neuromuscular weakness.Weakness in pregnancy - expect the unexpected.Recommendations for the use of albumin and immunoglobulins.New Frontiers in Subcutaneous Immunoglobulin Treatment.
P2860
Q21296685-2CF6D64C-EE21-4DD4-B405-84EAEF3CFD4AQ22252627-03B97AC3-67FE-4EEF-87DD-98177F9CF1FBQ24193522-3B70221A-05D5-4B6F-B21F-63BAD0FB5FE9Q24240016-6E117EE7-C8EC-46D4-B2B2-431D183B3E56Q24246272-EDFBEB85-339A-4155-A668-6B4D285325E4Q24246424-AFAA3693-609F-4DBB-A94D-CF85FA572110Q33901517-B96C6749-E7BF-4EBD-A435-654856DA0A4FQ34072287-B05FAEF9-6A66-4F13-A230-3843B1A63C76Q34122035-8781F73C-4402-49A6-AD39-A7F612AC8B45Q34409385-1E70E279-34EE-4774-9335-C6A6C96411BBQ35152989-CC2008C0-695E-4A9C-9490-E95BBBC60D97Q35729575-EE5767FD-F0BB-4DF7-9D4B-8C5740B6E5B7Q35765164-58EDAFBA-6738-4D4A-B1DA-250805AEA884Q37544140-CCA20649-1FBD-4381-9D60-732CFDEE5BF0Q37618385-7254583B-FF9D-44DE-AFB0-63892FCCF8B0Q37626126-91E19442-83CC-4560-86CA-FD0E946D4117Q37790256-19F67C3F-A060-45DC-BEB1-81501C42D197Q39934602-D8B8A9DB-AAF2-4E96-AFFD-9CC05F9CBE56Q40043727-BC4739A5-CD02-44DE-8449-31C227B3DD52Q41678367-8A330CF7-B2AC-4513-945E-14376AC70ECEQ42671923-26003F43-F827-4786-98C0-8CB4161D2620Q42775420-6B0C16DB-065B-42A2-BB73-9CFEC4ECCCE3
P2860
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Intravenous immunoglobulin for Guillain-Barré syndrome
@ast
Intravenous immunoglobulin for Guillain-Barré syndrome
@en
Intravenous immunoglobulin for Guillain-Barré syndrome
@en-gb
Intravenous immunoglobulin for Guillain-Barré syndrome
@nl
type
label
Intravenous immunoglobulin for Guillain-Barré syndrome
@ast
Intravenous immunoglobulin for Guillain-Barré syndrome
@en
Intravenous immunoglobulin for Guillain-Barré syndrome
@en-gb
Intravenous immunoglobulin for Guillain-Barré syndrome
@nl
prefLabel
Intravenous immunoglobulin for Guillain-Barré syndrome
@ast
Intravenous immunoglobulin for Guillain-Barré syndrome
@en
Intravenous immunoglobulin for Guillain-Barré syndrome
@en-gb
Intravenous immunoglobulin for Guillain-Barré syndrome
@nl
P2093
P2860
P1476
Intravenous immunoglobulin for Guillain-Barré syndrome
@en
P2093
Anthony V Swan
Jean Claude Raphaël
Richard AC Hughes
P2860
P356
10.1002/14651858.CD002063.PUB3
P577
2006-01-25T00:00:00Z